Apple Tree Partners related stories
All articles and analysis
VytronUS racks up $49 mln Series CVytronUS, a medical device company that develops new technologies that treat cardiac arrhythmias, has secured $49 million in Series C funding. The investors included Apple Tree Partners, NEA, BioStar Ventures and Windham Venture Partners.
- VC-backed CleanSlate Centers appoints new president/CEO
CleanSlate Centers, a network of outpatient addiction treatment centers, has promoted Gregory C. Marotta to president and CEO. Previously, Marotta was chief operating officer of the company. CleanSlate is backed by healthcare-focused venture firm Apple Tree Partners.
- Corvidia Therapeutics raises $26 mln in Series A funding
Corvidia Therapeutics, a biotechnology company developing cardiovascular therapies, raised $26 million in a Series A financing round co-led by Apple Tree Partners and existing backer Sofinnova Partners. In conjunction with the financing, Seth Harrison, managing partner at Apple Tree, and Adrien Lemoine of drugmaker AstraZeneca, will join Corvidia’s board.
IPO Aftermarket: Life sciences keep dominating as Pure Storage files its IPOThrough the end of July, VCJ reports that 50 VC-backed companies have gone public on the NYSE or Nasdaq exchanges
IPO Aftermarket: Fitbit surge dominates headlines, as biotech companies continue to roll outThrough the end of June, 42 VC-backed companies have gone public on the NYSE or Nasdaq exchanges
- Cure Forward picks up $15 mln from Apple Tree Partners
Newly launched patient activation company Cure Forward has raised $15 million in Series A funding. The investor was Apple Tree Partners.
- VC-backed Nivalis files for IPO
Boulder, Colorado-based Nivalis Therapeutics, a developer of drugs for patients with cystic fibrosis, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. Nivalis plans on trading the stock on the NASDAQ under the ticker symbol "NVLS." Cowen and Company and Stifel are serving as lead underwriters. The company's backers include Apple Tree Partners, Deerfield, RA Capital, Rock Springs Capital and Wellington Management.
- VytronUS names Pavlidis president & CEO
VytronUS Inc. said Monday that it named John Pavlidis its president and CEO, as well as a member of the board of directors. Most recently, Pavlidis was president and CEO of Endoscopic Technologies Inc. Sunnyvale, California-based VytronUS, a medical device company, raised $31.6 million in Series B financing in October.
- Avedro adds Apple Tree Partners' McIntyre to board
Boston-based Avedro Inc, an ophthalmic pharmaceutical and medical device company, has named David J. McIntyre to its board of directors. McIntyre is a partner at Apple Tree Partners.